California South University (CSU), USA

Email: Scholar.Researcher.Scientist@gmail.com, Alireza.Heidari@calsu.us

Qualifications

Jan 2014 – Jul 2014: Faculty of Chemistry, California South University (CSU), Irvine, California, USA. Participate in “Modern Molecular Electronic–Structure Computations Theory” and also “Nanochemistry” as postdoctoral research fellow.

Feb 2013 – Oct 2013: School of Chemistry, Faculty of Science, Monash University, Melbourne, Victoria, Australia. Participate in “Project Management” as postdoctoral research fellow.

Mar 2009 – Dec 2012: Faculty of Chemistry, California South University (CSU), Irvine, California, USA. Ph.D., D.Sc. Chemistry (Biophysical Chemistry) – GPA: 3.95/4.00 (19.75/20).

Sep 2006 – Aug 2008: Faculty of Chemistry, Islamic Azad University (IAU), North Tehran Branch, Tehran, Iran. M.Sc. Chemistry (Physical Chemistry) – GPA: 19.08/20.

Sep 2001 – Jul 2005: Faculty of Chemistry, Islamic Azad University (IAU), North Tehran Branch, Tehran, Iran. B.Sc. Chemistry (Pure Chemistry) – GPA: 19.08/20.

Publications (Selected)

1. A. Heidari, “Biochemical and Pharmacodynamical Study of Microporous Molecularly Imprinted Polymer Selective for Vancomycin, Teicoplanin, Oritavancin, Telavancin and Dalbavancin Binding”, Biochem Physiol 5: e146, 2016.

2. A. Heidari, “Spectroscopy and Quantum Mechanics of the Helium Dimer (He2+), Neon Dimer (Ne2+), Argon Dimer (Ar2+), Krypton Dimer (Kr2+), Xenon Dimer (Xe2+), Radon Dimer(Rn2+) and Ununoctium Dimer (Uuo2+) Molecular Cations”, Chem Sci J 7: e112, 2016.

3. A. Heidari, “A Novel Approach to Future Horizon of Top Seven Biomedical Research Topics to Watch in 2017: Alzheimer's, Ebola, Hypersomnia, Human Immunodeficiency Virus (HIV), Tuberculosis (TB), Microbiome/Antibiotic Resistance and Endovascular Stroke”, J Bioengineer & Biomedical Sci 7: e127, 2017.

4. A. Heidari, “A Comparative Computational and Experimental Study on Different Vibrational Biospectroscopy Methods, Techniques and Applications for Human Cancer Cells in Tumor Tissues Simulation, Modeling, Research, Diagnosis and Treatment”, Open J Anal Bioanal Chem 1 (1): 014–020, 2017.

5. A. Heidari, “X–Ray Diffraction (XRD), Powder X–Ray Diffraction (PXRD) and Energy–Dispersive X–Ray Diffraction (EDXRD) Comparative Study on Malignant and Benign Human Cancer Cells and Tissues under Synchrotron Radiation”, J Oncol Res; 2 (1): 1–14, 2018.

6. A. Heidari, “Biomedical Instrumentation and Applications of Biospectroscopic Methods and Techniques in Malignant and Benign Human Cancer Cells and Tissues Studies under Synchrotron Radiation and Anti–Cancer Nano Drugs Delivery”, Am J Nanotechnol Nanomed. 1 (1): 001–009, 2018.

7. A. Heidari, J. Esposito, A. Caissutti, “Debromoaplysiatoxin Time–Resolved Absorption and Resonance FT–IR and Raman Biospectroscopy and Density Functional Theory (DFT) Investigation of Vibronic–Mode Coupling Structure in Vibrational Spectra Analysis”, Applied Chemistry, 2 (1) 17–54, 2019.

8. A. Heidari, J. Esposito, A. Caissutti, “Nodularin Time–Resolved Absorption and Resonance FT–IR and Raman Biospectroscopy and Density Functional Theory (DFT) Investigation of Vibronic–Mode Coupling Structure in Vibrational Spectra Analysis”, Glob Imaging Insights 4 (2), 1–14, 2019.

Personal Websites:

1. http://calsu.us/index.php/member/prof-dr-alireza-heidari/

2. https://scholar.google.com/citations?user=2yKnXwYAAAAJ&hl=en